PMN logo

PMNProMIS Neurosciences

$10.35
$0.35
(3.27%)
Today
Closed $10.35
$0.00
(0.00%)
After Hours
Updated: 04:10 PM EDT
Reported EarningsMay 12
Mkt Cap$22.28M
Vol17,664.00
News
all
press releases
All You Need to Know About Promis Neurosciences (PMN) Rating Upgrade to Buy
Promis Neurosciences (PMN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
News Placeholder
More News
News Placeholder
Wall Street Analysts Think Promis Neurosciences (PMN) Could Surge 231.78%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 231.8% in Promis Neurosciences (PMN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks
News Placeholder
Promis Neurosciences (PMN) Projected to Post Quarterly Earnings on Monday
Promis Neurosciences (NASDAQ:PMN) will be releasing its Q1 2026 earnings before the market opens on Monday, May 11. (View Earnings Report at...
MarketBeat
News Placeholder
Insider Buying: Promis Neurosciences (NASDAQ:PMN) Director Buys 4,000 Shares of Stock
Promis Neurosciences (NASDAQ:PMN - Get Free Report) Director Patrick Kirwin purchased 4,000 shares of the stock in a transaction on Wednesday, April 22nd. The shares were bought at an average price...
MarketBeat
News Placeholder
Promis Neurosciences (NASDAQ:PMN) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Promis Neurosciences (NASDAQ:PMN - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the four brokerages that are covering the stock, MarketBeat.com reports. One...
MarketBeat
News Placeholder
Insider Buying: Promis Neurosciences (NASDAQ:PMN) Director Buys 1,000 Shares of Stock
Promis Neurosciences (NASDAQ:PMN - Get Free Report) Director Eugene Williams purchased 1,000 shares of the firm's stock in a transaction on Monday, March 2nd. The stock was bought at an average cost...
MarketBeat
News Placeholder
Promis Neurosciences (NASDAQ:PMN) Director Eugene Williams Buys 2,000 Shares
Promis Neurosciences (NASDAQ:PMN - Get Free Report) Director Eugene Williams purchased 2,000 shares of the company's stock in a transaction that occurred on Wednesday, March 4th. The shares were...
MarketBeat
News Placeholder
Eugene Williams Acquires 1,000 Shares of Promis Neurosciences (NASDAQ:PMN) Stock
Promis Neurosciences (NASDAQ:PMN - Get Free Report) Director Eugene Williams bought 1,000 shares of the company's stock in a transaction dated Monday, March 2nd. The stock was purchased at an average...
MarketBeat
News Placeholder
Promis Neurosciences (NASDAQ:PMN) Insider Buys $25,005.15 in Stock
Promis Neurosciences (NASDAQ:PMN - Get Free Report) insider Johanne Kaplan bought 1,629 shares of Promis Neurosciences stock in a transaction on Thursday, February 19th. The shares were purchased at...
MarketBeat
News Placeholder
Insider Buying: Promis Neurosciences (NASDAQ:PMN) Major Shareholder Acquires 700,741 Shares of Stock
Promis Neurosciences (NASDAQ:PMN - Get Free Report) major shareholder Abg Management Ltd. bought 700,741 shares of the company's stock in a transaction that occurred on Tuesday, February 3rd. The...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.